Mangrove Partners’s Aimei Health Technology Right AFJKR Stock Holding History
Bought
Maintained
Sold
Other funds holding AFJKR
Mangrove Partners's AFJKR Position: Q2 2025 in Review
Mangrove Partners sold out of Aimei Health Technology Right (AFJKR) in Q2 2025, closing a stake of 750,000 shares — an estimated $270K sold.
Mangrove Partners first reported a position in AFJKR in Q1 2024 and held it in 5 quarters. The position peaked at $270K in Q1 2025. 13 funds tracked by Wall St. Rank hold AFJKR as of Q2 2025.
- Mangrove Partners reported no remaining Aimei Health Technology Right position as of Q2 2025 after selling out during the quarter.
- Mangrove Partners sold 750,000 Aimei Health Technology Right shares in Q2 2025, an estimated $270K.
- Mangrove Partners first reported a position in Aimei Health Technology Right in Q1 2024 and held it in 5 quarters.
- Mangrove Partners's Aimei Health Technology Right position peaked at $270K in Q1 2025.
- 13 funds tracked by Wall St. Rank held Aimei Health Technology Right as of Q2 2025.
Based on Mangrove Partners's 13F filing for Q2 2025, filed 14 Aug 2025.